Significant association of hematinic deficiencies and high blood homocysteine levels with burning mouth syndrome  by Lin, Hung-Pin et al.
Journal of the Formosan Medical Association (2013) 112, 319e325Available online at www.sciencedirect.com
journal homepage: www.jfma-onl ine.comORIGINAL ARTICLE
Significant association of hematinic deficiencies and
high blood homocysteine levels with burning mouth
syndromeHung-Pin Lin a,b, Yi-Ping Wang a,b, Hsin-Ming Chen b,c,d, Ying-Shiung Kuo e,
Ming-Jane Lang e, Andy Sun b,d,*aGraduate Institute of Clinical Dentistry, National Taiwan University, Taipei, Taiwan
b School of Dentistry, National Taiwan University, Taipei, Taiwan
cGraduate Institute of Oral Biology, National Taiwan University, Taipei, Taiwan
dDepartment of Dentistry, National Taiwan University Hospital, College of Medicine, National Taiwan University,
Taipei, Taiwan
eDepartment of Dentistry, Far Eastern Memorial Hospital, Taipei, Taiwan
Received 19 January 2012; received in revised form 13 February 2012; accepted 17 February 2012KEYWORDS
burning mouth
syndrome;
gastric parietal cell
antibody;
hemoglobin;
homocysteine;
iron;
vitamin B12* Corresponding author. Department
E-mail address: andysun7702@yah
0929-6646/$ - see front matter Copyr
doi:10.1016/j.jfma.2012.02.022Background/Purpose: Burning mouth syndrome (BMS) is characterized by a burning sensation
of the oral mucosa in the absence of clinically apparent mucosal alterations. In this study,
we evaluated whether there was an intimate association of the deficiency of hemoglobin
(Hb), iron, vitamin B12, or folic acid; high blood homocysteine level; and serum gastric parietal
cell antibody (GPCA) positivity with BMS.
Methods: Blood Hb, iron, vitamin B12, folic acid, and homocysteine concentrations and the
serum GPCA level were measured in 399 BMS patients and compared with the corresponding
levels in 399 age- and sex-matched healthy control individuals.
Results: We found that 89 (22.3%), 81 (20.3%), 10 (2.5%), and six (1.5%) BMS patients had defi-
ciencies of Hb (men: <13 g/dL, women: <12 g/dL), iron (<60 mg/dL), vitamin B12 (<200 pg/
mL), and folic acid (<4 ng/mL), respectively. Moreover, 89 (22.3%) BMS patients had abnor-
mally high blood homocysteine level and 53 (13.3%) had serum GPCA positivity. BMS patients
had a significantly higher frequency of Hb, iron, or vitamin B12 deficiency; of abnormally
elevated blood homocysteine level; or of serum GPCA positivity than the healthy control group
(all p < 0.001 except for vitamin B12 deficiency, for which pZ 0.004). However, no significant
difference in frequency of folic acid deficiency (p Z 0.129) was found between BMS patients
and healthy control individuals.of Dentistry, National Taiwan University Hospital, No. 1, Chang-Te Street, Taipei 10048, Taiwan.
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320 H.-P. Lin et al.Conclusion: We conclude that there is a significant association of deficiency of Hb, iron,
and vitamin B12; abnormally high blood homocysteine level; and serum GPCA positivity with
BMS.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Burning mouth syndrome (BMS) is typically described by the
patients as a burning sensation of the oral mucosa in the
absence of clinically apparent mucosal alterations.1 BMS
affects 2e3% of adults and 14% of postmenopausal women.
Asians have a higher risk than Caucasians. Women are more
likely to have BMS than men. Its prevalence increases with
advancing age. BMS is also one of the most common disor-
ders seen in oral mucosal disease clinic.1,2
Both local and systemic factors are involved in the
etiology of BMS. Local factors include xerostomia, oral
candidiasis, oral submucous fibrosis, poorly fitting pros-
thesis, etc. Systemic factors include deficiencies of
thiamin, riboflavin, niacin, vitamin 12 (pernicious anemia),
folic acid, iron (iron-deficiency anemia and Plum-
mereVinson syndrome), and estrogen; diabetes mellitus;
hypothyroidism; Sjogren’s syndrome; anxiety; psychosocial
stress; depression; Parkinson’s disease; and others.1e3
Majority of these local or systemic factors have not been
proved in a well-controlled study.
The tongue, especially the tip and lateral borders, is
most commonly affected by the BMS.2 In this study, the
symptoms (such as dry mouth, burning sensation, numb-
ness, and loss or dysfunction of taste) and signs (such as
varicosity and candidiasis) of the tongue, blood chemistry
[including blood levels of hemoglobin (Hb), iron, vitamin
B12, folic acid, and homocysteine], and serum gastric
parietal cell antibody (GPCA) level in 399 BMS patients were
inquired, examined, and recorded. These data were
compared with corresponding data in 399 age- and sex-
matched healthy control individuals without oral mucosal
and systemic diseases. Statistical analyses were performed
to assess whether there was an intimate association of
deficiency of any specific hematinic factors, abnormally
high blood homocysteine level, and serum GPCA positivity
with BMS.Patients and methods
Participants
The study group consisted of 399 patients (95 men and 304
women, age range 28e91 years, mean 59.7  13.9 years)
with BMS. The normal control group consisted of 399 age-
(2 years of each patient’s age) and sex-matched healthy
control individuals (95 men and 304 women, age range
31e90 years, mean 59.6  14.0 years). All the patients and
control individuals were seen consecutively, diagnosed, and
treated in the Department of Dentistry of National Taiwan
University Hospital from July 2007 to June 2011. Patients
were diagnosed as having BMS when they complained ofburning sensation of the oral mucosa but no apparent
clinical oral mucosal abnormality was found (Fig. 1A and
1B). However, BMS patients with areca quid chewing habit
or autoimmune diseases (such as systemic lupus eryth-
ematosus, rheumatoid arthritis, Sjogren’s syndrome,
pemphigus vulgaris, and cicatricial pemphigoid) were
excluded. In addition, BMS patients with serum creatinine
concentrations indicative of renal dysfunction (men,
>131 mmol/L; women, >115 mmol/L) and those who re-
ported a history of stroke, heavy alcohol use, or diseases of
the liver, kidney, or coronary arteries were also excluded.4
Healthy control individuals had either dental caries or
periodontal diseases, but no oral mucosal or systemic
diseases. None of the BMS patients had taken any
prescription medication for BMS at least 3 months prior to
entering the study. For BMS patients and healthy controls,
the symptoms (such as dry mouth, burning sensation,
numbness, and loss or dysfunction of taste) and signs [such
as candidiasis and varicosity (Fig. 1C)] of the tongue were
inquired, examined, and recorded. Blood samples were
drawn from BMS patients and healthy controls to measure
the blood Hb, iron, vitamin B12, folic acid, and homo-
cysteine concentrations and the serum GPCA levels. This
study was reviewed and approved by the Institutional
Review Board at the National Taiwan University Hospital.Determination of blood Hb, iron, vitamin B12, folic
acid, and homocysteine concentrations
Concentrations of blood Hb, iron, vitamin B12, folic acid,
and homocysteine were determined by the routine tests
performed in the Department of Laboratory Medicine of
National Taiwan University Hospital.Determination of serum GPCA level
Serum GPCA level was detected by the indirect immuno-
fluorescence technique with rat stomach as a substrate, as
described previously.5,6 In brief, 5 mm thick cryostat
sections of substrate tissues on slides were reacted with
serially diluted patients’ and control individuals’ sera in
a moist chamber at room temperature for 30 minutes. The
initial dilution of the patients’ and control individuals’ sera
was 1:20 with phosphate-buffered saline (PBS). After
washing, the sections were incubated with fluorescein-
isothiocyanate-labeled goat antihuman immunoglobulin G
(IgG) antiserum (Boehringer Mannheim Biochemicals, Indi-
anapolis, IN, USA), which had been prediluted and kept in
a dropper vial by the manufacturer and was ready to use for
another 30 minutes. The sections were washed again,
mounted with buffered glycerine, and examined with an
Olympus fluorescence microscope (Olympus, Tokyo,
Figure 1 Clinical photographs of the tongue and lingual varicosity in patients with burning mouth syndrome. (A) The tongue of
a 61-year-old female patient showing no definite lesion on the dorsal surface. (B) The tongue of a 56-year-old female patient
showing no apparent alteration on the dorsal surface. (C) Lingual varicosity on the ventral surface of the tongue in a 62-year-old
female patient.
Hematinic deficiencies and burning mouth syndrome 321Japan). Sera were scored as positive when they produced
fluorescence at a dilution of 20-fold or more.
Diagnosis of oral candidiasis
For each BMS patient, two exfoliative cytologic slides were
prepared from the dorsal surface of the tongue. One slide
was stained with periodic acid-Schiff (PAS) method and
examined for the presence of candidal hyphae and yeasts.
The presence of bright magenta-colored hyphae or pseu-
dohyphae confirmed the diagnosis of candidiasis. The other
slide was prepared with 20% potassium hydroxide for the
rapid identification of the fungal organisms. The dorsal
surface of the tongue was diagnosed as having candidiasis
when either one of the cytologic preparations was positive
for candidal hyphae or yeasts.1 Exfoliative cytologic slides
were prepared from the dorsal surface of the normal
tongues of only a few healthy control individuals. These
slides were stained with PAS or treated with 20% potassium
hydroxide and then examined by light microscopy for the
presence of Candida albicans.
Statistical analysis
Comparisons of the mean blood levels of Hb, iron, vitamin
B12, folic acid, and homocysteine between 399 AG patients
and 399 age- and sex- matched healthy control individuals
were performed by Student t test. The differences in
frequency of Hb, iron, vitamin B12, or folic acid deficiency;
of abnormally high blood homocysteine level; or of serum
GPCA positivity between 399 BMS patients and 399 healthy
control individuals or our previously reported 176 patientswith atrophic glossitis (AG)7 were compared by chi-square
test. In addition, the differences in frequency of the pres-
ence of symptoms or signs between BMS patients and
healthy control individuals or AG patients were also
compared by chi-square test. The result was considered to
be significant if p < 0.05.
Results
The mean blood concentrations of Hb, iron, vitamin B12,
folic acid, and homocysteine in 399 BMS patients and 399
age- and sex-matched healthy control individuals are shown
in Table 1. Because men usually have higher blood levels of
Hb and iron than women, these two mean levels were
calculated separately for men and women. We found that
BMS patients had significantly lower mean Hb (p < 0.001 for
both men and women) and iron levels (p < 0.001 for both
men and women) and significantly higher mean homo-
cysteine levels (p < 0.001) than healthy controls (Table 1).
However, no significant difference in the mean serum
vitamin B12 (pZ 0.522) or folic acid level (pZ 0.137) was
demonstrated between them (Table 1).
According to the World Health Organization criteria,
men with Hb <13 g/dL and women with Hb <12 g/dL were
defined as having Hb deficiency or anemia.8 Furthermore,
patients with serum iron level <60 mg/dL,9 serum vitamin
B12 level <200 pg/mL (148 pmol/L),4 or folic acid level
<4 ng/mL (10 nmol/L)10 were defined as having iron,
vitamin B12, or folic acid deficiency, respectively. In addi-
tion, patients with blood homocysteine level >12.4 mmol/L
(which was the mean blood homocysteine level of healthy
controls plus two standard deviations) were defined as
Table 1 Mean blood concentrations of Hb, iron, vitamin B12, folic acid, and homocysteine in 399 patients with BMS and in 399
age- and sex-matched healthy control individuals.
Patients with
BMS (n Z 399)
Healthy control
individuals (n Z 399)
p (Student t test)
Mean  SD Range Mean  SD Range
Hb (g/dL)
Men (n Z 95) 13.7  1.5 7.8e16.6 14.9  0.7 13.2e16.7 <0.001a
Women (n Z 304) 12.6  1.3 7.1e15.6 13.4  0.8 12.0e15.4 <0.001a
Iron (mg/dL)
Men (n Z 95) 90.0  29.7 33e158 104.9  23.4 65e160 <0.001a
Women (n Z 304) 80.9  23.4 10e160 96.2  23.8 56e160 <0.001a
Vitamin B12 (pg/mL) 677.5  280.0 150e1000 688.3  186.5 265e998 0.522
Folic acid (ng/mL) 13.8  6.3 2.9e24.0 14.4  5.0 5.8e24.0 0.137
Homocysteine (mmol/L) 10.9  7.6 4.8e133.1 8.6  1.9 4.6e15.8 <0.001a
BMS Z burning mouth syndrome; Hb Z hemoglobin.
a Comparisons of the mean blood levels of Hb, iron, vitamin B12, folic acid and homocysteine between 399 BMS patients and 399 age-
and sex-matched healthy control individuals by Student t test with p < 0.05.
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mentioned definitions, 89 (22.3%), 81 (20.3%), 10 (2.5%),
and six (1.5%) BMS patients were diagnosed as having Hb,
iron, vitamin B12, and folic acid deficiencies, respectively
(Table 2). Moreover, 89 (22.3%) BMS patients had abnor-
mally high blood homocysteine level and 53 (13.3%) had
serum GPCA positivity (Table 2). BMS patients had a signifi-
cantly higher frequency of Hb, iron, or vitamin B12 defi-
ciency; of abnormally elevated blood homocysteine level;
or of serum GPCA positivity than healthy control individuals
(all p < 0.001 except for vitamin B12 deficiency, for which
p Z 0.004; Table 2). However, no significant difference in
frequency of folic acid deficiency (p Z 0.129) was found
between BMS patients and healthy control individuals.
When the frequencies of Hb, iron, vitamin B12, or folic
acid deficiency; of high blood homocysteine level; and of
serum GPCA positivity were further compared between 399
BMS patients and our previously reported 176 AG patients,7Table 2 Number and percentage of individuals with hemoglobin
high homocysteine level; or with serum GPCA positivity in 399
control individuals.
Factor Patients with
BMS (n Z 399
Hemoglobin deficiency (men <13 g/dL,
women <12 g/dL)
89 (22.3%)
Iron deficiency (<60 mg/dL) 81 (20.3%)
Vitamin B12 deficiency (<200 pg/mL) 10 (2.5%)
Folic acid deficiency (<4 ng/mL) 6 (1.5%)
High homocysteine levelb (>12.4 mmol/L) 89 (22.3%)
GPCA positivity 53 (13.3%)
BMS Z burning mouth syndrome; GPCA Z gastric parietal cell antibo
a Comparison of frequency of hemoglobin, iron, vitamin B12, or folic
of serum GPCA positivity between 399 BMS patients and 399 age- and
p < 0.05.
b High homocysteine level was defined as patients with the homocyst
control individuals plus two standard deviations.we found that AG patients had a higher frequency of
vitamin B12 deficiency (p Z 0.012) and of GPCA positivity
(p < 0.001) than BMS patients (Table 3).
The tongue-associated symptoms and signs in 399 BMS
patients and 399 age- and sex-matched healthy control
individuals are shown in Table 4. Burning sensation of the
tongue (100%) was found to be the most common symptom
and lingual varicosity (92.5%) was the most frequent sign
in 399 BMS patients. In addition, BMS patients had signifi-
cantly higher frequencies of the tongue-associated symp-
toms and signs than healthy control individuals (all
p < 0.001; Table 4). Because exfoliative cytologic slides
were prepared for only a few healthy control individuals,
we did not know the exact Candida prevalence in healthy
control individuals.
In addition, if these tongue-associated symptoms and
signs were further compared between 399 BMS patients and
176 AG patients,7 we found that AG patients had a higher, iron, vitamin B12, or folic acid deficiency; with abnormally
patients with BMS and in 399 age- and sex-matched healthy
)
Healthy control
individuals (n Z 399)
p (chi-square test)
0 (0%) <0.001a
12 (3.0%) <0.001a
0 (0%) 0.004a
1 (0.3%) 0.129
19 (4.8%) <0.001a
8 (2.0%) <0.001a
dy.
acid deficiency; of abnormally high blood homocysteine level; or
sex- matched healthy control individuals by chi-square test with
eine level greater than the mean of homocysteine level of healthy
Table 3 Number and percentage of individuals with hemoglobin, iron, vitamin B12, or folic acid deficiency; with abnormally
high homocysteine level; or with serum GPCA positivity in 399 patients with BMS and in previously reported 176 patients with
AG.7
Factor Patients with
BMS (n Z 399)
Patients with
AG (n Z 176)
p (chi-square test)
Hemoglobin deficiency (men <13 g/dL,
women <12 g/dL)
89 (22.3%) 39 (22.2%) 0.944
Iron deficiency (<60 mg/dL) 81 (20.3%) 47 (26.7%) 0.111
Vitamin B12 deficiency (<200 pg/mL) 10 (2.5%) 13 (7.4%) 0.012a
Folic acid deficiency (<4 ng/mL) 6 (1.5%) 3 (1.7%) 0.853
High homocysteine levelb (>12.4 mmol/L) 89 (22.3%) 38 (21.6%) 0.935
GPCA positivity 53 (13.3%) 47 (26.7%) <0.001a
AG Z atrophic glossitis; BMS Z burning mouth syndrome; GPCA Z gastric parietal cell antibody.
a Comparison of frequency of hemoglobin, iron, vitamin B12, or folic acid deficiency; of abnormally high blood homocysteine level; or
of serum GPCA positivity between 399 BMS patients and 176 AG patients by chi-square test with p < 0.05.
b High homocysteine level was defined as patients with the homocysteine level greater than the mean of homocysteine level of healthy
control individuals plus two standard deviations.
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of taste (p Z 0.043), or lingual varicosity (p Z 0.004) than
BMS patients (Table 5).Discussion
This study showed that BMS patients had significantly higher
frequencies of Hb, iron, and vitamin B12 deficiency; of
abnormally elevated blood homocysteine level; and of
serum GPCA positivity than healthy control individuals.
Both BMS and AG patients complained of burning sensation
of the tongue.1 When BMS and AG patients were further
compared, we demonstrated a significantly higher
frequency of vitamin B12 deficiency and of serum GPCA
positivity in AG patients than in BMS patients. However,
there was no significant difference in the frequency of Hb
or iron deficiency or in the frequency of abnormally high
blood homocysteine level between AG and BMS patients.
Patients with GPCA positivity had destruction of gastric
parietal cells by an autoimmune mechanism, resulting in
deficiency of intrinsic factor, lack of absorption of vitamin
B12 from small intestine, and finally vitamin B12 defi-
ciency.1 This can explain why patients with GPCA positivity
usually also have lower serum vitamin B12 level. BecauseTable 4 Tongue-associated symptoms and signs in 399 patients
individuals.
Symptoms and signs
of the tongue
Patients with
BMS (n Z 399)
Dry mouth 302 (75.7%)
Burning sensation 399 (100.0%)
Numbness 175 (43.9%)
Dysfunction of taste 79 (19.8%)
Varicosity 369 (92.5%)
Candidiasis 32 (8.0%)
BMS Z burning mouth syndrome.
a Comparison of frequency of the presence of symptom or sign be
control individuals by chi-square test with p < 0.05.vitamin B12 deficiency and GPCA positivity are associated
with pernicious anemia, our findings suggest that AG
patients may be more likely to have pernicious anemia than
BMS patients. In fact, if pernicious anemia is defined as the
presence of an Hb concentration of <13 g⁄dL for men and
<12 g⁄dL for women, a mean corpuscular volume 100 fL,
and a low serum vitamin B12 level (<200 pg/mL),11 we
discovered that only 13 (7.4%) of the 176 AG patients7 and
10 (2.5%) of the 399 BMS patients could be classified as
having pernicious anemia. Therefore, our data also support
the fact that there is a higher frequency of pernicious
anemia in AG patients than in BMS patients.
Higher blood homocysteine levels are associated with
increased rates of coronary heart disease and stroke,
because high blood homocysteine level can cause oxidative
stress, damage endothelium, and enhance thrombogenicity
in experimental studies.12e15 This study found an abnor-
mally higher blood homocysteine level in 22.3% of BMS
patients, whereas it could be discovered in only 4.8% of
healthy control individuals. This high blood homocysteine
level in BMS patients could be due to deficiency in folic
acid, vitamin B6, and vitamin B12, because a previous study
has shown that a supplementation with folic acid, vitamin
B6, and vitamin B12 can reduce blood homocysteine
levels.12 Indeed, deficiency of vitamin B12 was morewith BMS and in 399 age- and sex-matched healthy control
Healthy control
individuals (n Z 399)
p (chi-square test)
0 (0%) <0.001a
0 (0%) <0.001a
0 (0%) <0.001a
0 (0%) <0.001a
0 (0%) <0.001a
Unknown
tween 399 BMS patients and 399 age- and sex-matched healthy
Table 5 Tongue-associated symptoms and signs in 399 patients with BMS and in previously reported 176 patients with AG.7
Symptoms and signs of the tongue Patients with BMS (n Z 399) Patients with AG (n Z 176) p (chi-square test)
Dry mouth 302 (75.7%) 139 (79.0%) 0.452
Burning sensation 399 (100.0%) 176 (100%) NSD
Numbness 175 (43.9%) 101 (57.4%) 0.004a
Dysfunction of taste 79 (19.8%) 49 (27.8%) 0.043a
Varicosity 369 (92.5%) 174 (98.9%) 0.004a
Candidiasis 32 (8.0%) 22 (12.5%) 0.123
AG Z atrophic glossitis; BMS Z burning mouth syndrome; NSD Z no significant difference.
a Comparison of frequency of the presence of symptom or sign between 399 BMS patients and 176 AG patients by chi-square test with
p < 0.05.
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controls in this study. The deficiency of vitamin B12 finally
resulted in high blood homocysteine level in BMS patients.
Burning sensation, dry mouth, and numbness of the
tongue were the three most common symptoms of BMS
patients, and could be found in 100%, 75.7%, and 43.9% of
BMS patients in this study, respectively. Iron and vitamin
B12 are related to the health of oral epithelium. Long-term
dry mouth and iron or vitamin B12 deficiency may cause at
least partial atrophy of the tongue epithelium in BMS
patients, although the alteration is so subtle that it cannot
be recognized by clinical visual examination. Therefore,
the spicy molecules in the saliva could easily diffuse
through the atrophic epithelium into the subepithelial
connective tissue of the tongue mucosa, irritate the free
sensory nerve endings, and in turn induce burning sensation
and numbness of the tongue.
Loss or dysfunction of taste was a minor symptom of BMS
and could be found in 19.8% of BMS patients in the present
study. The chemical substances should be dissolved in saliva
because the taste cells in taste buds can perceive only the
dissolved substances. Xerostomia was described in 75.7% of
the BMS patients. Decreased secretion of saliva in turn
resulted in loss or dysfunction of taste in BMS patients.
Moreover, oral candidiasis, vitamin B12 deficiency, iron
deficiency, and medication are all associated with loss or
dysfunction of taste.1,16 In addition, Femiano et al analyzed
the causes of taste disturbance in BMS patients. Of 142 BMS
patients, 61 revealed the habitual use of drugs having
a documented interference with taste perception, 35 had
pathologies or a previous history of use of drugs that are
known to affect the gustatory system, and the remaining 46
patients had no associated pathology or habitual use of
drugs.17
Varicosities are abnormally dilated and tortuous veins
that are often found on the ventral surface of the tongue in
aged individuals due to the age-related loss of connective
tissue tone supporting the veins.1 Moreover, xerostomia is
a common problem that has been reported in 25% of older
adults.1 A number of developmental, iatrogenic, systemic,
and local factors may play a role in the cause of xero-
stomia. However, xerostomia in older adults is more likely
the result of medications, because aged patients are prone
to taking drugs associated with xerostomia to overcome
their systemic or psychotic disorders.1 In this study, the
mean age of 399 BMS patients was 59.7 years. Therefore, it
was not surprising to find lingual varicosity in 92.5% and drymouth in 75.7% of 399 BMS patients. Because normal and
sufficient saliva can provide cleansing and antimicrobial
activity, there is an increased prevalence of oral candidiasis
in patients with xerostomia.1 We suggest that the candidi-
asis on the tongue surfaces of our 32 (8.0%) BMS patients
may be at least partially due to the high incidence (75.7%)
of dry mouth.
Our results demonstrated that 22.3%, 20.3%, and 2.5% of
our 399 BMS patients had deficiencies of Hb, iron, and
vitamin B12, respectively. Moreover, 22.3% and 13.3% of our
399 BMS patients had abnormally high blood homocysteine
level and serum GPCA positivity, respectively. We also
found a significantly higher frequency of Hb, iron, or
vitamin B12 deficiency; of abnormally elevated blood
homocysteine level; or of serum GPCA positivity in our 399
BMS patients than in 399 healthy control individuals. These
findings suggest that there is a significant association of
deficiency of Hb, iron, and vitamin B12; abnormally high
blood homocysteine level; and serum GPCA positivity with
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